| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
GRYT Health is a team of cancer survivors and caregivers that helps cancer patients, survivors and caregivers have the info to choose whats right for them at every step of their unique situation.
United Pharmacists Enterprises Ltd is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Putnam County Operation Life is a Greencastle, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Minority Health Profession is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.